SCHEMBL14190879

SCHEMBL14190879

CCc1ccc(OC(C)C)c(OC)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.48
THRB P10828 1/20 0.48
PTGS2 P35354 1/20 0.47
MAPK1 P28482 2/20 0.47
ALDH1A1 P00352 2/20 0.47
MAPT P10636 1/20 0.47
LMNA P02545 2/20 0.46
HTT P42858 2/20 0.46
GAA P10253 1/20 0.46
TSHR P16473 1/20 0.46
ATM Q13315 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ALOX15 P16050 1/20 0.45
ALOX12 P18054 1/20 0.45
ADRA1D P25100 1/20 0.45
ADRA1A P35348 1/20 0.45
ADRA1B P35368 1/20 0.45
CSNK2A1 P68400 2/20 0.45
LDHA P00338 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8372213 0.93 CA2 (0.52) CA2SMN1; SMN2PTGS2ALDH1A1LMNA
SCHEMBL16606256 0.90 CSNK2A1 (0.49) CA2SMN1; SMN2THRBPTGS2MAPK1
SCHEMBL18888242 0.86 HDAC1 (0.49) CA2SMN1; SMN2PTGS2ALDH1A1LMNA
SCHEMBL31275634 0.84 CA2 (0.71) CA2SMN1; SMN2PTGS2ALDH1A1LMNA
SCHEMBL31428 0.84 CA2 (0.71) CA2SMN1; SMN2PTGS2ALDH1A1LMNA
SCHEMBL7791117 0.84 SMN1; SMN2 (0.50) CA2SMN1; SMN2THRBMAPK1ALDH1A1
SCHEMBL580037 0.84 CA2 (0.50) CA2SMN1; SMN2THRBMAPK1LMNA
SCHEMBL13111719 0.84 CA2 (0.50) CA2SMN1; SMN2PTGS2MAPK1ALDH1A1
SCHEMBL12775553 0.84 LDHA (0.51) CA2SMN1; SMN2THRBMAPK1LMNA
SCHEMBL12845579 0.82 CSNK2A1 (0.42) SMN1; SMN2THRBGAACSNK2A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008075172-A2 NICOTINAMIDE DERIVATIVES AS INHIBITORS OF H-PGDS AND THEIR USE FOR TREATING PROSTAGLANDIN D2 MEDIATED DISEASES PFIZER PRODUCTS INC. (US) 2008-06-26 WO disclosed